Literature DB >> 6633518

Isolation and characterization of copper-binding sites of human ceruloplasmin.

K S Raju.   

Abstract

A tryptic cleavage procedure was used to obtain stable copper-containing peptide regions of human ceruloplasmin. Tryptic digestion-derived copper peptides were fractionated by gel filtration chromatography, yielding two fractions, one with an apparent molecular weight of 11000 and the other 1000. The high molecular weight fraction (11K fraction) was found to contain 50% of the copper atoms of the ceruloplasmin molecule and behaved as a single copper-containing component by gel filtration chromatography and by isoelectric focusing. The low molecular weight fraction (1K fraction) was found to be a mixture of three or four copper peptides by isoelectric focusing. Acrylamide gel electrophoresis studies, amino acid composition analysis and terminal amino acid determinations showed the 11K fraction to be a complex composed of at least three peptides arising from different regions of the ceruloplasmin molecule. Two of the peptides of the 11K complex appear to be derived from the 19K fragment of the ceruloplasmin molecule (18); one peptide in the complex appears to correspond to the aspartic acid-rich portion, residues 7-30, and the other to the histidine-rich portion, residues 103-157. Most preparations of ceruloplasmin are reported to consist of three non-covalently linked fragments that have molecular weights of 67K, 50K and 19K. Dwulet and Putnam (20) proposed a model for the sequence structure of ceruloplasmin where the molecule exhibits a three-fold repeat pattern of two alternating structures, here termed X and Y.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6633518     DOI: 10.1007/BF00228772

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  18 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

Review 2.  Strategy and tactics in protein chemistry.

Authors:  B S Hartley
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

3.  Preparative isoelectric focusing with Pevikon as supporting medium.

Authors:  B M Harpel; F Kueppers
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

4.  Complete amino acid sequence of a histidine-rich proteolytic fragment of human ceruloplasmin.

Authors:  I B Kingston; B L Kingston; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  An extremely acidic copper-containing protein from chromaffin granules.

Authors:  N A Grigoryan; R M Nalbandyan; H Ch Buniatian
Journal:  Biochem Biophys Res Commun       Date:  1981-06-16       Impact factor: 3.575

6.  Internal duplication and evolution of human ceruloplasmin.

Authors:  F E Dwulet; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

7.  Complete amino acid sequence of a 50,000-dalton fragment of human ceruloplasmin.

Authors:  F E Dwulet; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

8.  Caeruloplasmin: a multi-functional metalloprotein of vertebrate plasma.

Authors:  E Frieden
Journal:  Ciba Found Symp       Date:  1980

9.  The amino acid sequence of plastocyanin from Vicia faba L. (broad bean).

Authors:  J A Ramshaw; M D Scawen; D Boulter
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

10.  Ceruloplasmin, copper ions, and angiogenesis.

Authors:  K S Raju; G Alessandri; M Ziche; P M Gullino
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

View more
  1 in total

1.  Isolation and partial nucleotide sequence of the laccase gene from Neurospora crassa: amino acid sequence homology of the protein to human ceruloplasmin.

Authors:  U A Germann; K Lerch
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.